Global Myeloproliferative Disorders Drugs/Treatment Market Size, Share, Trends & Growth Analysis Report Segmented By Disorder Type (Philadelphia Chromosome-Positive (Ph+) CML, Philadelphia Chromosome-Negative (Ph-) MPNs, Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Other Disorder Types), Drug Class, Route Of Administration, End-Use, And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034